Windtree Therapeutics, a U.S.-based biotechnology firm listed on the NASDAQ, has entered a groundbreaking $60 million investment agreement with Build and Build Corp. This move marks a major pivot from its traditional business focus into the digital asset space. The deal envisions another $140 million of investment, bringing the total investment to a level of […]